Investor Center

Ardea is focused on the development of small-molecule drugs that address large pharmaceutical markets.  The Company plans to source development candidates from both their internal drug discovery programs and continued in-licensing efforts.  Ardea’s initial therapeutic areas of focus are viral diseases, cancer and inflammatory diseases.  The Company believes that they are well-positioned to create shareholder value through their development activities, given the ability to achieve clinical proof-of-concept relatively quickly and cost-effectively in these disease categories.